A summary of the update on cardiovascular implantable electronic device infections and their management : A scientific statement from the American Heart Association

Journal of the American Dental Association

Volumn 142, Issue 2, 2011, Pages 159-165

  Lockhart, Peter B ^a   Baddour, Larry M ^b   Epstein, Andrew E ^c   Erickson, Christopher C ^d,e,f   Knight, Bradley P ^g   Levison, Matthew E ^h   Masoudi, Frederick A ⁱ   Okum, Eric J ^j   Wilson, Walter R ^k   Beerman, Lee B ^l   Bolger, Ann F ^m,n   Estes III, N A Mark ^o   Gewitz, Michael ^p,q   Mewburger, Jane W ^r   Schron, Eleanor B ^s   Taubert, Kathryn A ^t  

^a CAROLINAS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL AND MEDICAL CENTER   (United States)

^g Northwestern Medical Center   (United States)

^h DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ DENVER HEALTH MEDICAL CENTER   (United States)

^j Mercy Reg Hlth Sys Gtr C   (United States)

^k Department of Health Sciences Research   (United States)

^l CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ SAN FRANCISCO GENERAL HOSPITAL   (United States)

^o TUFTS MEDICAL CENTER   (United States)

^p WESTCHESTER MEDICAL CENTER   (United States)

^q NEW YORK MEDICAL COLLEGE   (United States)

^r BOSTON CHILDREN S HOSPITAL   (United States)

^s NATIONAL EYE INSTITUTE   (United States)

^t WORLD HEART FEDERATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952433525     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2011.0058     Document Type: Article

References (69)

1. Baddour LM, Bettmann MA, Bolger AF, et al.; American Heart Association. Nonvalvular cardiovascular device-related infections. Circulation 2003;108(16):2015-2031. (Pubitemid 37296549)
2. Hayes DL, Furman S. Cardiac pacing: How it started, where we are, where we are going. Pacing Clin Electrophysiol 2004;27(5):693-704. (Pubitemid 38648470)
3. Epstein AE, Demarco JP, EUenbogen KA, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons (published correction appears in Circulation 2009;120[5]:e34-e35). Circulation 2008;117(21):e350-e408.
4. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 2008;23(suppl 1):13-19.
5. Uslan DZ, Tleyjeh IM, Baddour LM, et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J 2008;155(5):896-903.
6. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: A population based study. J Interv Card Electrophysiol 2008;22(1):65-70.
7. Schwartz IS, Pervez N. Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. JAMA 1971;218(5): 736-737.
8. Corman LC, Levison ME. Sustained bacteremia and transvenous cardiac pacemakers. JAMA 1975;233(3):264-266.
9. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg 1975;69(1):1-7.
10. Bluhm G. Pacemaker infections: A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl 1985;699:1-62.
11. Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis: Report of 44 cases and review of the literature. Medicine (Baltimore) 1994;73(6):299-305.
12. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303(6):322-324. (Pubitemid 10040022)
13. Mela T, MeGovern BA, Garan H, et al. Long-term infection rates associated with pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001;88(7):750-753.
14. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004;147(4):582-586. (Pubitemid 38900441)
15. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007;167(7):669-675. (Pubitemid 46598459)
16. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006;48(3):590-591. (Pubitemid 44093958)
17. Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29(2):142-145.
18. Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009;95(9):715-720.
19. Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45(2):166-173. (Pubitemid 47041006)
20. Hug D, Balde M, Pavin D, et al.; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116(12):1349-1355. (Pubitemid 47417560)
21. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: A meta-analysis. Circulation 1998;97(18):1796-1801. (Pubitemid 28213623)
22. Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: Observations in 335 patients over 10 years. Br Heart J 1995;73(1):20-24.
23. Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: Epidemiology, infection control, and management. Clin Infect Dis 1998;27(2):265-269.
24. Camus C, Leport C, Raffi F, Michelet C, Cartier F, Vilde JL. Sus-tained bacteremia in 26 patients with a permanent endocardial pacemaker: Assessment of wire removal. Clin Infect Dis 1993;17(1):46-55. (Pubitemid 23197564)
25. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: Clinical presentation and management. Circulation 1997;95(8):2098-2107. (Pubitemid 27184278)
26. Da Costa A, Lelievref H, Kirkorian G, et al. Role of the preaxil-lary flora in pacemaker infections: A prospective study. Circulation 1998;97(18):1791-1795. (Pubitemid 28213622)
27. Fu EY, Shepard RK. Permanent pacemaker infections. Card Electrophysiol Rev 1999;3(1):39-41.
28. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133(8):604-608.
29. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49(18):1851-1859. (Pubitemid 46661104)
30. Villamil Cajoto I, Rodríguez Framil M, Van den Eynde Collado A, José VUlacián Vicedo M, Canedo Romero C. Permanent transvenous pacemaker infections: An analysis of 59 cases. Eur J Intern Med 2007;18(6):484-488. (Pubitemid 47379538)
31. del Río A, Anguera I, Miró JM, et al.; Hospital Clinic Endocarditis Study Group. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003;124(4):1451-1459. (Pubitemid 37290057)
32. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994;7(1):117-140. (Pubitemid 24038092)
33. Chacko ST, Chandy ST, Abraham OC, et al. Pacemaker endocarditis caused by Pseudomonas aeruginosa treated successfully. J Assoc Physicians India 2003;51:1021-1022. (Pubitemid 41279853)
34. Kouvousis NM, Lazaros GA, Christoforatou EG, et al. Acremonium species pacemaker site infection. Hellenic J Cardiol 2003;44:83-87.
35. Amin M, Gross J, Andrews C, Furman S. Pacemaker infection with Mycobacterium avium complex. Pacing Clin Electrophysiol 1991;14(2 pt 1):152-154.
36. Giannella M, Valerio M, Franco J A, Marin M, Bouza E, Muñoz P. Pacemaker infection due to Mycobacterium fortuitum: the role of universal 16S rRNA gene PCR and sequencing. Diagn Microbiol Infect Dis 2007;57(3):337-339. (Pubitemid 46330645)
37. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104(9):1029-1033. (Pubitemid 32803880)
38. Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 1994; 38(10):2231-2237. (Pubitemid 24304209)
39. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S. Staphylococcus aureus bacteremia and endocarditis: The Grady Memorial Hospital experience with methicillin-sensitive S aureus and methi-cillin-resistant S aureus bacteremia. Am Heart J 2004;147(3):536-539. (Pubitemid 38880879)
40. Kemodle DS, Barg NL, Kaiser AB. Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 1988;32(2):202-208. (Pubitemid 18061375)
41. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect 2002;4(4):481-489. (Pubitemid 34270685)
42. Darouiche RO. Device-associated infections: A macroproblem that starts with microadherence. Clin Infect Dis 2001;33(9):1567-1572. (Pubitemid 34246153)
43. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988;1(3):281-299.
44. Veenstra GJ, Cremers FF, van Dyk H, Fleer A. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacterid 1996;178(2):537-541. (Pubitemid 26030610)
45. Wilkinson BJ. Biology. In: Crossley KB, Archer GL, ed. The Staphylococci in Human Disease. New York: Churchill Livingstone; 1997:1-38.
46. François P, Vaudaux P, Lew PD. Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann Vase Surg 1998;12(1):34-40. (Pubitemid 28028014)
47. Vaudaux PE, Francois P, Proctor RA, et al. Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts (published correction appears in Infect Immun 1995;63[8]:3239)
48. Infect Immun 1995;63(2):585-590.
49. Heilmann C, Schweitzer O, Gerke C, Vanittanakom N, Mack D, Gotz F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 1996;2(X5):1083-1091. (Pubitemid 26198280)
50. Bayston R, Penny SR. Excessive production of mucoid substance in staphylococcus SUA: A possible factor in colonisation of Holter shunts. Dev Med Child Neurol Suppl 1972;27:25-28.
51. Baddour LM, Barker LP, Christensen GD, Parisi JT, Simspon WA. Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes. J Clin Microbiol 1990;28(4):676-679. (Pubitemid 20123817)
52. Seifert H, Wisplinghoff H, Schnabel P, von EiffC. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg Infect Dis 2003;9(10):1316-1318. (Pubitemid 37210577)
53. Seifert H, Oltmanns D, Becker K, Wisplinghoff H, von EiffC. Staphylococcus lugdunensis pacemaker-related infection. Emerg Infect Dis 2005;11(8):1283-1286. (Pubitemid 41045339)
54. Boelens JJ, Dankert J, Murk JL, et al. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis 2000;181(4):1337-1349. (Pubitemid 30252538)
55. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Götz F. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 1997;179(15): 4706-4712. (Pubitemid 27339714)
56. Balwit JM, van Langevelde P, Vann JM, Proctor RA. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured 56. Love CJ, WilkofiFBL, Byrd CL, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000;23(4 pt 1):544-551.
57. Gaynor SL, Zierer A, Lawton JS, Gleva MJ, Damiano RJ Jr, Moon MR. Laser assistance for extraction of chronically implanted endocardial leads: infectious versus noninfectious indications. Pacing Clin Electrophysiol 2006;29(12):1352-1358. (Pubitemid 44952385)
58. Field ME, Jones SO, Epstein LM. How to select patients for lead extraction. Heart Rhythm 2007;4(7):978-985. (Pubitemid 46959211)
59. Johansen JB, Nielsen JC, Arnsbo P, Moller M, Pedersen AK, Mortensen PT. Higher incidence of pacemaker infection after replacement than after first implantation: experiences from 36,076 consecutive patients. Heart Rhythm 2006;3 (5 suppl):S102-S103.
60. Kay GN, B linker J A, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 1999;HKX23):2344-2352.
61. Bracke F, Meijer A, Van Gelder B. Extraction of pacemaker and implantable cardioverter defibrillator leads: patient and lead characteristics in relation to the requirement of extraction tools. Pacing Clin Electrophysiol 2002;25(7):1037-1040. (Pubitemid 34828056)
62. de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter- defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial (published correction appears in Circ Arrhythm Electrophysiol 2009;2[l]: Circ Arrhythm Electrophysiol 2009;2(1):29-34.
63. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008;117(24):3118-3125.
64. Wilson W, Taubert KA, Gewitz M, et al.; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group (published correction appears in Circulation 2007;116[15]:e376-e377). Circulation 2007;166(15):1736-1754.
65. Tong DC, Rothwell BR. Antibiotic prophylaxis in dentistry: A review and practice recommendations. JADA 2000;131(3):366-374.
66. Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ. Decision-making on the use of antimicrobial prophylaxis for dental procedures: A survey of infectious disease consultants and review. Clin Infect Dis 2002;34(12):1621-1626. (Pubitemid 34615448)
67. Lockhart PB, Loven B, Brennan MT, Fox PC. The evidence base for the efficacy of antibiotic prophylaxis in dental practice. JADA 2007;138(4):458-474.
68. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43(11):5721-5732. (Pubitemid 41612354)
69. Bahrani-Mougeot FK, Paster BJ, Coleman S, Ashar J, Barbuto S, Lockhart PB. Diverse and novel oral bacterial species in blood following dental procedures. J Clin Microbiol 2008;46(6):2129-2132. (Pubitemid 351831862)